"Omics" as the filtering gateway between environment and phenotype: The inflammatory bowel diseases example

American Journal of Medical Genetics, Part A

Volumn 152 A, Issue 12, 2010, Pages 3022-3025

  Kellermayer, Richard ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CPG ISLAND; CROHN DISEASE; DEAMINATION; DNA METHYLATION; ENTERITIS; EPIGENETICS; GENETIC PREDISPOSITION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNE SYSTEM; MEIOSIS; METABOLOMICS; NONHUMAN; NUTRITIONAL STATUS; PHENOTYPE; PRIORITY JOURNAL; ULCERATIVE COLITIS; BIOLOGICAL MODEL; ENVIRONMENT; GENETIC DRIFT; GENETICS; GENOMICS;

ENVIRONMENT; GENETIC DRIFT; GENOMICS; HUMANS; INFLAMMATORY BOWEL DISEASES; METABOLOMICS; MODELS, BIOLOGICAL; PHENOTYPE;

EID: 78649647805     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.33726     Document Type: Article

References (25)

1. Abramson O, Durant M, Mow W, Finley A, Kodali P, Wong A, Tavares V, McCroskey E, Liu L, Lewis JD, Allison JE, Flowers N, Hutfless S, Velayos FS, Perry GS, Cannon R, Herrinton LJ. 2010. Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006. J Pediatr. 157:233-239.e1.
2. Bailey MT, Dowd SE, Parry NM, Galley JD, Schauer DB, Lyte M. 2010. Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. Infect Immun 78:1509-1519.
3. Barnett M, Bermingham E, McNabb W, Bassett S, Armstrong K, Rounce J, Roy N. 2010. Investigating micronutrients and epigenetic mechanisms in relation to inflammatory bowel disease. Mutat Res. 690:71-80.
4. Benchimol EI, Guttmann A, Griffiths AM, Rabeneck L, Mack DR, Brill H, Howard J, Guan J, To T. 2009. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: Evidence from health administrative data. Gut 58:1490-1497.
5. Bestor TH. 2000. The DNA methyltransferases of mammals. Hum Mol Genet 9:2395-2402.
6. 2/ascorbate-induced formation of 5-methylcytosine glycol at CpG sites in duplex DNA. Nucleic Acids Res 37:6635-6643.
7. de Zoeten EF, Wang L, Sai H, Dillmann WH, Hancock WW. 2010. Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gastroenterology 138:583-594.
8. Dolinoy DC, Das R, Weidman JR, Jirtle RL. 2007. Metastable epialleles, imprinting, and the fetal origins of adult diseases. Pediatr Res 61:30R-37R.
9. Feinberg AP, Irizarry RA. 2010. Evolution in health and medicine Sackler colloquium: Stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease. Proc Natl Acad Sci USA 107:1757-1764.
10. Fuentealba LC, Eivers E, Geissert D, Taelman V, De Robertis EM. 2008. Asymmetric mitosis: Unequal segregation of proteins destined for degradation. Proc Natl Acad Sci USA 105:7732-7737.
11. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schaffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, Hätscher N, Pfeifer D, Sykora KW, Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U, Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB, Grimbacher B, Klein C. 2009. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 361:2033-2045.
12. Gluckman PD, Hanson MA, Mitchell MD. 2010. Developmental origins of health and disease: Reducing the burden of chronic disease in the next generation. Genome Med 2:14.
13. Gupta N, Bostrom AG, Kirschner BS, Ferry GD, Gold BD, Cohen SA, Winter HS, Baldassano RN, Abramson O, Smith T, Heyman MB. 2010. Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients. Inflamm Bowel Dis 16:638-644.
14. Jablonka E, Raz G. 2009. Transgenerational epigenetic inheritance: Prevalence, mechanisms, and implications for the study of heredity and evolution. Q Rev Biol 84:131-176.
15. Kellermayer R. 2006. Translational readthrough induction of pathogenic nonsense mutations. Eur J Med Genet 49:445-450.
16. Kellermayer R. 2007. Genetic drift. Physiologic noise obscures genotype-phenotype correlations. Am J Med Genet Part A 143A:1306-1307.
17. Kellermayer R, Balasa A, Zhang W, Lee S, Mirza S, Chakravarty A, Szigeti R, Laritsky E, Tatevian N, Smith CW, Shen L, Waterland RA. 2010. Epigenetic maturation in colonic mucosa continues beyond infancy in mice. Hum Mol Genet. 19:2168-2176.
18. Laroui H, Dalmasso G, Nguyen HT, Yan Y, Sitaraman SV, Merlin D. 2010. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model. Gastroenterology 138:843-853.e1-2.
19. Lees CW, Satsangi J. 2009. Genetics of inflammatory bowel disease: Implications for disease pathogenesis and natural history. Expert Rev Gastroenterol Hepatol 3:513-534.
20. Morgan HD, Dean W, Coker HA, Reik W, Petersen-Mahrt SK. 2004. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: Implications for epigenetic reprogramming. J Biol Chem 279:52353-52360.
21. Popp C, Dean W, Feng S, Cokus SJ, Andrews S, Pellegrini M, Jacobsen SE, Reik W. 2010. Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463:1101-1105.
22. Santucci L, Fiorucci S, Rubinstein N, Mencarelli A, Palazzetti B, Federici B, Rabinovich GA, Morelli A. 2003. Galectin-1 suppresses experimental colitis in mice. Gastroenterology 124:1381-1394.
23. Sartor RB. 2006. Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3:390-407.
24. Waterland RA, Michels KB. 2007. Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr 27:363-388.
25. Waterland RA, Travisano M, Tahiliani KG. 2007. Diet-induced hypermethylation at agouti viable yellow is not inherited transgenerationally through the female. FASEB J 21:3380-3385.